UCL Discovery Stage
UCL home » Library Services » Electronic resources » UCL Discovery Stage

Assessment of long-term neurodevelopmental outcome following trials of medicinal products in newborn infants

Marlow, N; Doyle, LW; Anderson, P; Johnson, S; Bhatt-Mehta, V; Natalucci, G; Darlow, BA; ... International Neonatal Consortium (INC); + view all (2019) Assessment of long-term neurodevelopmental outcome following trials of medicinal products in newborn infants. Pediatric Research 10.1038/s41390-019-0526-1. (In press). Green open access

[thumbnail of s41390-019-0526-1_reference.pdf]
Preview
Text
s41390-019-0526-1_reference.pdf - Published Version

Download (1MB) | Preview

Abstract

There is significant uncertainty over the role of assessment of long-term neurodevelopmental outcome (LTO) in neonatal clinical trials. A multidisciplinary working group was established to identify key issues in this area and to make recommendations about optimal approaches to evaluate LTO in therapeutic trials in newborns, which can be developed by sponsors and investigators with other key stakeholders. A key consideration for neonatal trials is the potential for the investigational product to cause widespread effects and drives the need to assess outcome in multiple organs. Thus investigators must assess whether the product has an impact on the brain and the potential for it to cause potential effects on LTO. Critically, is assessment of LTO an important direct therapeutic target or a safety outcome? Such decisions and outcomes need to be specific to the product being studied and use published data, only considering expert opinion when prior evidence does not exist. In designing the trial, the balance of benefits, costs, and burdens of assessments to the researcher and families need to be considered. Families and parent advocates should be involved in design and execution of the study. A framework is presented for use by all key stakeholders to determine the need, nature, and duration of LTO assessments in regulatory trials involving newborn infants.

Type: Article
Title: Assessment of long-term neurodevelopmental outcome following trials of medicinal products in newborn infants
Location: United States
Open access status: An open access version is available from UCL Discovery
DOI: 10.1038/s41390-019-0526-1
Publisher version: https://doi.org/10.1038/s41390-019-0526-1
Language: English
Additional information: This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL EGA Institute for Womens Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL EGA Institute for Womens Health > Neonatology
URI: https://discovery-pp.ucl.ac.uk/id/eprint/10080123
Downloads since deposit
4,028Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item